In truth, BioAge was forced to discontinue the STRIDES Phase 2 trial after several subjects exhibited elevated liver enzyme levels, indicating potential organ damage. Consequently, the Company ...

Feed Enzymes Alliance to its equal partner Novonesis, a global leader in biosolutions, for ?1.5 billion. The dsm-firmenich activities to be ...

PRNewswire/ -- dsm-firmenich, innovators in nutrition, health, and beauty, today announces the sale of its stake in the Feed ...

New York, New York-- (Newsfile Corp. - February 9, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc. (NASDAQ: BIOA) and ...

Pharmaceutical ads are difficult to avoid in American television programming and a growing number of them promote a class of ...

(NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the appointment of Arthur Levin, PhD, to the Company’s Strategic ...

Metalloenzymes utilize a metal ion cofactor in the enzyme active site to perform essential biological functions. This diverse class of targets has historically been difficult to drug due to small ...

A new ML-guided platform can design thousands of new enzymes, predict how they will behave in the real world, and test their ...

Enzymes are crucial to life. They are nature's little catalysts. In the gut, they help us digest food. They can enhance perfumes or get laundry cleaner with less energy. Enzymes also make potent drugs ...

Rubisco is the enzyme responsible for carbon fixation in plants, algae and many bacteria. A screen of a comprehensive library of rubisco variants (each with a different single-amino-acid mutation ...